Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma entities : Bridgebio pharma, inc. save search
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 10, 2024
Published: 2024-04-10 (Crawled : 12:00) - biospace.com/
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: -4.11%
H: 0.81%
C: 0.15%
pharma nasdaq grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-10 (Crawled : 12:00) - bridgebio.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: -4.11%
H: 0.81%
C: 0.15%
pharma nasdaq grants
BridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR) Imaging Evidence Consistent with Clinical Improvement Observed in the ATTRibute-CM Phase 3 Study in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Published: 2024-04-07 (Crawled : 20:20) - bridgebio.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
| Email alert
Add to watchlist
pharma cardiac imaging study
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 20, 2024
Published: 2024-03-20 (Crawled : 12:00) - biospace.com/
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 0.46%
H: 1.37%
C: 0.25%
pharma nasdaq grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-20 (Crawled : 12:00) - bridgebio.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 0.46%
H: 1.37%
C: 0.25%
pharma nasdaq grants
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock - March 06, 2024
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 2.36%
H: 2.34%
C: -2.81%
pharma offering
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
Published: 2024-03-06 (Crawled : 05:00) - bridgebio.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 2.36%
H: 2.34%
C: -2.81%
pharma offering
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
Published: 2024-03-04 (Crawled : 21:00) - globenewswire.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: -2.32%
H: 0.62%
C: -6.34%
pharma offering
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
Published: 2024-03-04 (Crawled : 08:00) - bridgebio.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 0.93%
H: 0.08%
C: -10.03%
pharma agreement
BridgeBio Pharma and Kyowa Kirin Announce Partnership with an Upfront Payment of $100 Million for an Exclusive License on Infigratinib in Skeletal Dysplasias in Japan
Published: 2024-02-07 (Crawled : 12:30) - globenewswire.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 0.0%
H: 1.04%
C: -0.73%
partnership pharma japan license million payment
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-06 (Crawled : 12:30) - globenewswire.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: -0.15%
H: 2.03%
C: 1.31%
pharma nasdaq grants
BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Published: 2024-02-05 (Crawled : 12:30) - bridgebio.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: -1.21%
H: 1.43%
C: 0.39%
pharma drug food treatment application
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Including No Mortality Reported in the Trial at 30 Months
Published: 2024-02-02 (Crawled : 12:00) - globenewswire.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: -1.41%
H: 5.51%
C: 3.26%
pharma positive trial results study
Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics
Published: 2024-01-30 (Crawled : 12:00) - prnewswire.com
NVTA | News | $0.019 0.0% 22M
|
Health Services
|
| O: 8.11%
H: 0.96%
C: -9.4%
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: -1.16%
H: 1.07%
C: -3.5%
rare pharma disease genetic therapeutics
BridgeBio Pharma Secures up to $1.25 Billion of Capital from Blue Owl and CPP Investments to Accelerate the Development and Launch of Genetic Medicines
Published: 2024-01-18 (Crawled : 12:00) - globenewswire.com
OWL | $18.765 0.35% 390K
|
Finance and Insurance
|
| O: 0.79%
H: 0.0%
C: -0.79%
MS | News 0 d | $93.9 0.15% 780K
|
Finance
|
| O: 0.5%
H: 0.18%
C: -1.1%
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 1.79%
H: 8.2%
C: -0.03%
pharma investments genetic blue
BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine
Published: 2024-01-10 (Crawled : 22:00) - globenewswire.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: -1.4%
H: 0.08%
C: -0.31%
pharma positive publication results study
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - January 10, 2024
Published: 2024-01-10 (Crawled : 13:00) - biospace.com/
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 0.0%
H: 2.19%
C: 0.43%
pharma nasdaq grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-10 (Crawled : 12:30) - globenewswire.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 0.0%
H: 2.19%
C: 0.43%
pharma nasdaq grants
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 22:00) - bridgebio.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 0.45%
H: 1.24%
C: -2.89%
pharma conference
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-08 (Crawled : 12:30) - globenewswire.com
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: 1.16%
H: 1.44%
C: -4.35%
pharma nasdaq grants
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.93 64.96% 55M
|
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
TROO | $1.57 44.04% 2.8M
|
Manufacturing
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
WHLM | $6.61 30.12% 400K
|
Commercial Services
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.